PULM MT Newswires 5 days ago Gyre Therapeutics Signs All-Stock Deal to Acquire Cullgen for $300 Million
PULM PR Newswire 5 days ago Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
